Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan.

ABSTRACT:

SUBMITTER: Hashimoto T 

PROVIDER: S-EPMC8610564 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature